Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications

Hasniza Zaman Huri, Lay Peng Lim, Soo Kun Lim
  • Drug Design Development and Therapy, August 2015, Dove Medical Press
  • DOI: 10.2147/dddt.s85676

Glycaemic control and antidiabetic drugs

What is it about?

Good glycemic control can delay the progression of kidney diseases in type 2 diabetes mellitus (T2DM) patients with renal complications. To date, the association between antidiabetic agents and glycemic control in this specific patient population is not well established.

Why is it important?

This study aimed to identify antidiabetic regimens as well as other factors that associated with glycemic control in T2DM patients with different stages of chronic kidney disease (CKD).

open access logoRead Publication

http://dx.doi.org/10.2147/dddt.s85676

The following have contributed to this page: Miss Lim Lay Peng, Dr Soo Kun Lim, and Dr Hasniza Zaman Huri